![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 05, 2020 11:38:47 AM
Frankly, I have never encountered a ticker so controlled by MM’s than BRTXQ before. Therefore, I had to do some research to better understand them. I would encourage those that are new to this or want more information about them to simply google “market makers” to fully understand them and the impact they have on the market/stock tickers.
What I learned is (I could had guessed it any way) BRTXQ is the perfect stock to be involved with as an MM. Makes sense because we all know how great this play is based on our DD. Because of all the hype of BRTXQ it’s the perfect ticker to make a lot of money from. MM’s make a lot of money from setting the Bid/Ask price... yes they virtually set the price for tickers they are in. They make money from the difference of the spread. In a high volume day that is a lot of money. We can agree they are making a boatload of money off of BRTXQ!
We all wonder why we have not reached the price levels we thought we would by now. Well, that’s because the MM’s have complete control of the shares price. One does not need to have level 2 to tell how much they are in control. Just watch how the bid/ask SP moves and it’s easy to tell. This is a MM’s honey whole so they’ll manipulate it as they see fit to make money. Will this pass? I think it will; however, don’t ask me when, because I don’t own a crystal ball.
Is this legal you may ask? I guess it depends on point of view and motivation/client behind it. How “I” understand it is that pure manipulation of the stock price for financial gain is greatly frowned upon; nevertheless, action against this practice is rarely taken especially in the OTC. They could be working for a client such as broker or financial firm. In this case it could be Auctus, however I have no knowledge of it one way or another. What I do know is that by making a market for BRTXQ and keeping the volume up and the cash flowing (high volume days moves a lot of cash) it helps with BRTXQ’s capital needs by keeping liquidity for them... if I understand that correctly. So if this is true, this will help us in the long run as BRTXQ gains strength financially. As they become more secure financially the less need for MM’s involvement... if this is the case. Again, these are just possibilities for the MM’s activities, I’m not saying it is or is not, just could be.
The bottom line is if there is money to be made the MM’s will keep working BRTXQ. They will not make a trade unless there is money to make. As we have seen they will manipulate the SP to make as much as they can. They will also play off of information (or the lack of expected information) as a catalysts for the direction they want to go make money. I think we saw that this morning at opening. No 8-K yet means shaky hands for the weak investor.
I feel as BRTXQ builds business momentum and they move forward on the information we know of, we will see the share price rise. MM’s have control for now; however, when positive info starts flowing they will be forced to flow with it and make big money at the same time we do. This could be a stretch for a positive thought but here it goes anyway... MM’s may be the instrument needed to help get BRTXQ to a major exchange. I see they can make a lot of money doing so as we know we will by them setting the SP higher and higher as positive information flows out from BRTXQ... I know... it a stretch. Again, my thoughts and I hope it will add encouragement to those that are troubled with the MM’s control.
I’m holding strong and long.
Sgt
Recent BRTX News
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
- BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants • GlobeNewswire Inc. • 04/03/2024 08:38:00 PM
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K • GlobeNewswire Inc. • 04/01/2024 11:45:00 AM
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/11/2024 08:15:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:34:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:43:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:40:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:27:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:25:23 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM